Introduction
Biobin 500mg injection:

Biobin 500mg injection contains the active substance Cytarabine. It is
an antineoplastic drug that belongs to the class antimetabolite. It is used
alone or with other chemotherapy medications to treat certain types of
leukemias (a type of blood cancer with too many white blood cells), including
acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML). It is also
indicated to use alone or with other chemotherapy drugs to treat and prevent
meningeal leukemia (cancer in the membrane that covers and protects the spinal
cord and brain).

Do not take Biobin 500mg injection if you are allergic to Cytarabine or
any other ingredients of this medicine. Inform your physician if you have
difficulties in body coordination, or taking any other anti-cancer medications,
decreased bone marrow functioning, have liver problems, or have undergone
dialysis immediately before or after treatment with this medicine.

Biobin 500mg injection may cause an increased uric acid level in your
blood, your doctor will tell you if you need to take any medicine to control
this. Notify your physician if you have sudden signs of allergy, such as rash,
itching, or hives on the skin, swelling of the face, lips, mouth, or throat,
shortness of breath, or wheezing. It is unknown whether this medicine can be
administered in patients with kidney failure, inform your doctor if you have
any kidney diseases.

Uses of Biobin 500mg injection:

·
Acute myeloid leukemia

·
Chronic myelogenous leukemia

·
Meningeal leukemia

How
to consume Biobin 500mg injection:

Biobin 500mg injection will be given to you in a hospital setting by a
trained healthcare professional. This medicine may be given by solution for
injection/infusion (using a syringe) under the skin (subcutaneous) or into a
vein (intravenously) or into a muscle (intramuscularly), or into the spine
(intrathecal). Your doctor will decide the dose, route of administration, and
duration of the treatment based on your disease condition, severity, and other
factors.